Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.3 billion.
Market Cap
1.11T
Revenue
105.3B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-39.26%
Dividend Yield
0.05%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.10B | 0.66% | 985,400 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 74.99B | -1.49% | 773,663 | 14.25B |
| 3 | ARGX | argenx SE | 49.24B | -1.72% | 365,040 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 47.15B | -0.67% | 761,481 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.46B | 0.07% | 91,532 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.62B | 1.91% | 1,936,344 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.22B | 2.26% | 824,052 | 3.70B |
| 8 | RVMD | Revolution Medicines, Inc. | 23.26B | -2.41% | 2,887,084 | - |
| 9 | RPRX | Royalty Pharma plc | 22.77B | -0.68% | 1,009,691 | 2.35B |
| 10 | GMAB | Genmab A/S | 20.89B | -4.19% | 5,509,143 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.87B | 0.99% | 1,199,281 | 4.81B |
| 12 | MRNA | Moderna, Inc. | 16.29B | 5.93% | 9,884,782 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.95B | -1.57% | 4,362,437 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.74B | 0.29% | 6,294,509 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.26B | -0.41% | 1,300,006 | - |
| 16 | ASND | Ascendis Pharma A/S | 12.66B | -4.08% | 576,576 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | -1.27% | 2,260,936 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.92B | -2.57% | 1,777,828 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.42B | 1.37% | 186,045 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.93B | -0.11% | 1,023,120 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.75B | -1.39% | 1,912,231 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.55B | -0.25% | 1,088,370 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.26B | -1.34% | 744,746 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.23B | -0.26% | 645,384 | 6.23M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.96B | 2.07% | 462,070 | 561.26M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.79B | -3.46% | 1,142,915 | 829.45M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.76B | 6.07% | 433,608 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.38B | -0.78% | 539,654 | 1.24B |
| 29 | KRYS | Krystal Biotech, Inc. | 8.21B | 0.42% | 146,272 | 373.16M |
| 30 | NUVL | Nuvalent, Inc. | 8.17B | -0.86% | 233,836 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.63B | -1.56% | 804,688 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.50B | -1.99% | 1,627,750 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.81B | -3.85% | 327,284 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.13B | -2.46% | 635,806 | - |
| 35 | GPCR | Structure Therapeutics Inc. | 6.13B | 4.26% | 1,372,414 | - |
| 36 | COGT | Cogent Biosciences, Inc. | 5.90B | -1.25% | 1,820,768 | - |
| 37 | PTCT | PTC Therapeutics, Inc. | 5.85B | -3.65% | 535,565 | 1.78B |
| 38 | BLTE | Belite Bio, Inc | 5.78B | 3.00% | 135,579 | - |
| 39 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.72B | -1.10% | 444,179 | 1.54M |
| 40 | KYMR | Kymera Therapeutics, Inc. | 5.58B | -1.87% | 434,439 | 43.74M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.45B | 0.02% | 235,999 | - |
| 42 | IBRX | ImmunityBio, Inc. | 5.43B | 39.49% | 167,630,671 | 82.56M |
| 43 | IMVT | Immunovant, Inc. | 5.30B | 0.56% | 1,273,072 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.11B | -3.55% | 479,099 | 209.22M |
| 45 | CRSP | CRISPR Therapeutics AG | 5.10B | -1.20% | 1,108,929 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.95B | 1.69% | 298,167 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.71B | -1.33% | 161,649 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.60B | -3.07% | 625,204 | - |
| 49 | TGTX | TG Therapeutics, Inc. | 4.47B | -0.42% | 1,861,570 | 531.90M |
| 50 | CGON | CG Oncology, Inc. | 4.43B | 3.55% | 733,427 | 2.17M |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.43B | 0.10% | 2,469,287 | 598.70M |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 4.39B | -2.30% | 561,416 | 1.05B |
| 53 | ADMA | ADMA Biologics, Inc. | 4.18B | 0.29% | 1,350,839 | 488.56M |
| 54 | LEGN | Legend Biotech Corporation | 4.11B | 0.57% | 1,342,536 | 909.05M |
| 55 | TERN | Terns Pharmaceuticals, Inc. | 4.02B | -0.05% | 1,372,482 | - |
| 56 | ACLX | Arcellx, Inc. | 3.98B | 0.83% | 373,158 | 35.90M |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.83B | 6.40% | 2,925,096 | - |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.83B | -0.83% | 173,210 | 251.23M |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.68B | -1.10% | 791,200 | 741.17M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.58B | -0.72% | 317,277 | 35.24M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.32B | 1.04% | 503,260 | - |
| 62 | LQDA | Liquidia Corporation | 3.29B | -2.41% | 2,684,274 | 69.22M |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.24B | -0.87% | 1,224,333 | 15.00M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -1.44% | 687,051 | 317.93M |
| 65 | VRDN | Viridian Therapeutics, Inc. | 3.16B | 0.39% | 824,839 | 70.79M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.14B | -0.75% | 396,107 | 214.83M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.10B | -1.52% | 726,838 | 7.50M |
| 68 | BEAM | Beam Therapeutics Inc. | 3.08B | -2.78% | 1,137,696 | 55.70M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.03B | -3.10% | 760,997 | 366.10M |
| 70 | ALMS | Alumis Inc. | 2.99B | -0.87% | 1,300,001 | 22.12M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.88B | 2.24% | 1,115,843 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80B | -0.83% | 539,167 | 578.20M |
| 73 | DNLI | Denali Therapeutics Inc. | 2.80B | -4.58% | 943,832 | - |
| 74 | ERAS | Erasca, Inc. | 2.76B | 1.67% | 8,791,180 | - |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.75B | 1.89% | 1,311,068 | - |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.72B | 0.85% | 750,083 | 240.00M |
| 77 | IRON | Disc Medicine, Inc. | 2.71B | 0.93% | 242,772 | - |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 2.67B | -1.63% | 663,823 | 252.75M |
| 79 | TLX | Telix Pharmaceuticals Limited | 2.61B | 4.31% | 159,283 | 664.23M |
| 80 | SYRE | Spyre Therapeutics, Inc. | 2.59B | 0.79% | 257,135 | - |
| 81 | MLYS | Mineralys Therapeutics, Inc. | 2.56B | 3.25% | 932,685 | - |
| 82 | WVE | Wave Life Sciences Ltd. | 2.54B | -1.53% | 1,982,993 | 109.23M |
| 83 | APLS | Apellis Pharmaceuticals, Inc. | 2.50B | -3.60% | 1,272,685 | 1.02B |
| 84 | TVTX | Travere Therapeutics, Inc. | 2.50B | -1.48% | 1,312,564 | 435.83M |
| 85 | IMNM | Immunome, Inc. | 2.47B | -1.93% | 1,323,027 | 9.68M |
| 86 | AAPG | Ascentage Pharma Group International | 2.46B | -0.48% | 3,384 | 54.52M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.43B | 0.43% | 18,495,778 | 43.69M |
| 88 | OCUL | Ocular Therapeutix, Inc. | 2.40B | -0.31% | 5,337,716 | 55.78M |
| 89 | MESO | Mesoblast Limited | 2.28B | -1.35% | 114,609 | 17.20M |
| 90 | SLNO | Soleno Therapeutics, Inc. | 2.27B | 0.91% | 790,890 | 98.68M |
| 91 | GLPG | Galapagos NV | 2.22B | -1.67% | 106,201 | 336.64M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | -0.89% | 1,366,133 | 2.41B |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.18B | -3.70% | 1,020,333 | 630.60M |
| 94 | OLMA | Olema Pharmaceuticals, Inc. | 2.15B | -6.17% | 537,106 | - |
| 95 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | -0.93% | 415,355 | 825.94M |
| 96 | ZLAB | Zai Lab Limited | 2.06B | -1.38% | 244,809 | 441.63M |
| 97 | NUVB | Nuvation Bio Inc. | 2.01B | -4.56% | 3,830,804 | 26.75M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -0.07% | 503,443 | 265.81M |
| 99 | MAZE | Maze Therapeutics, Inc. | 1.96B | 2.14% | 163,214 | 2.50M |
| 100 | NRIX | Nurix Therapeutics, Inc. | 1.93B | 1.01% | 900,425 | 83.69M |
| 101 | VCEL | Vericel Corporation | 1.90B | -2.72% | 250,986 | 258.72M |
| 102 | DNTH | Dianthus Therapeutics, Inc. | 1.88B | -0.45% | 318,508 | 3.08M |
| 103 | GLUE | Monte Rosa Therapeutics, Inc. | 1.87B | -1.70% | 651,472 | 181.54M |
| 104 | NBY | NovaBay Pharmaceuticals, Inc. | 1.85B | 15.84% | 2,587,258 | 10.30M |
| 105 | MBX | MBX Biosciences, Inc. | 1.84B | -0.02% | 347,476 | - |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | - | 464,161 | 111.30M |
| 107 | TNGX | Tango Therapeutics, Inc. | 1.76B | 11.89% | 5,015,030 | 66.50M |
| 108 | ZYME | Zymeworks Inc. | 1.75B | -0.76% | 350,605 | 134.48M |
| 109 | SION | Sionna Therapeutics, Inc. | 1.74B | 0.51% | 171,283 | - |
| 110 | BHVN | Biohaven Ltd. | 1.73B | 9.44% | 3,222,435 | - |
| 111 | CLDX | Celldex Therapeutics, Inc. | 1.72B | 0.82% | 484,780 | 2.60M |
| 112 | KOD | Kodiak Sciences Inc. | 1.69B | 2.25% | 545,792 | - |
| 113 | IMCR | Immunocore Holdings plc | 1.68B | 1.37% | 523,187 | 379.59M |
| 114 | UPB | Upstream Bio, Inc. | 1.68B | 0.32% | 280,396 | 2.80M |
| 115 | STOK | Stoke Therapeutics, Inc. | 1.66B | -0.45% | 755,936 | 205.63M |
| 116 | ARDX | Ardelyx, Inc. | 1.64B | -3.84% | 3,367,445 | 398.23M |
| 117 | PHVS | Pharvaris N.V. | 1.63B | -2.34% | 165,248 | - |
| 118 | MNKD | MannKind Corporation | 1.61B | -6.09% | 5,123,434 | 313.79M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.60B | 1.63% | 439,086 | - |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | -2.19% | 671,856 | 44.79M |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.58B | 5.96% | 940,168 | - |
| 122 | PGEN | Precigen, Inc. | 1.55B | 6.04% | 2,343,363 | 6.31M |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.54B | -0.62% | 243,573 | - |
| 124 | FTRE | Fortrea Holdings Inc. | 1.53B | 4.01% | 1,338,496 | 2.76B |
| 125 | OCS | Oculis Holding AG | 1.46B | 6.04% | 365,894 | 992.00K |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.46B | 5.90% | 4,700,826 | 57.53M |
| 127 | INVA | Innoviva, Inc. | 1.45B | -1.82% | 312,190 | 388.52M |
| 128 | QURE | uniQure N.V. | 1.42B | 4.05% | 1,174,347 | 15.75M |
| 129 | SVRA | Savara Inc. | 1.41B | -0.94% | 1,153,392 | - |
| 130 | TRVI | Trevi Therapeutics, Inc. | 1.36B | -1.39% | 671,756 | - |
| 131 | ATAI | AtaiBeckley Inc. | 1.32B | -1.89% | 1,772,199 | 3.02M |
| 132 | NVAX | Novavax, Inc. | 1.30B | 2.51% | 4,073,463 | 1.06B |
| 133 | IMTX | Immatics N.V. | 1.30B | -2.62% | 288,021 | 99.45M |
| 134 | RLAY | Relay Therapeutics, Inc. | 1.28B | -2.88% | 1,715,074 | 8.36M |
| 135 | RAPP | Rapport Therapeutics, Inc. | 1.28B | 0.06% | 139,705 | - |
| 136 | PHAR | Pharming Group N.V. | 1.27B | 3.25% | 14,044 | 362.27M |
| 137 | IVA | Inventiva S.A. | 1.27B | 6.37% | 322,867 | 19.93M |
| 138 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | -6.12% | 1,686,906 | 6.31M |
| 139 | ANAB | AnaptysBio, Inc. | 1.26B | -1.84% | 205,811 | 169.47M |
| 140 | CAPR | Capricor Therapeutics, Inc. | 1.26B | 1.12% | 693,267 | 11.13M |
| 141 | EYPT | EyePoint, Inc. | 1.25B | -4.73% | 499,468 | 42.34M |
| 142 | XERS | Xeris Biopharma Holdings, Inc. | 1.24B | 1.01% | 1,191,980 | 266.14M |
| 143 | ABCL | AbCellera Biologics Inc. | 1.23B | -1.79% | 4,748,978 | 35.33M |
| 144 | SANA | Sana Biotechnology, Inc. | 1.22B | -1.93% | 1,952,924 | - |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.20B | 2.75% | 1,129,248 | - |
| 146 | PVLA | Palvella Therapeutics, Inc. | 1.20B | -2.89% | 179,444 | - |
| 147 | SEPN | Septerna, Inc. | 1.17B | -4.31% | 250,526 | 22.05M |
| 148 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | 4.51% | 1,344,982 | - |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 1.09B | -6.68% | 1,093,107 | 147.19M |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.08B | 1.40% | 463,614 | 15.00M |
| 151 | SPRY | ARS Pharmaceuticals, Inc. | 1.07B | -2.43% | 606,459 | 142.77M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.05B | 0.91% | 161,011 | 1.40M |
| 153 | GHRS | GH Research PLC | 1.05B | 0.06% | 128,205 | - |
| 154 | AKTS | Aktis Oncology, Inc. | 1.05B | -2.92% | 272,450 | 5.56M |
| 155 | DAWN | Day One Biopharmaceuticals, Inc. | 1.05B | -3.05% | 2,943,141 | 133.67M |
| 156 | NBTX | Nanobiotix S.A. | 1.03B | 1.32% | 12,360 | 11.93M |
| 157 | TBPH | Theravance Biopharma, Inc. | 1.02B | 0.12% | 171,854 | 80.33M |
| 158 | CMPX | Compass Therapeutics, Inc. | 1.02B | -1.12% | 1,172,710 | 850.00K |
| 159 | MRVI | Maravai LifeSciences Holdings, Inc. | 997.26M | 5.69% | 1,096,699 | 192.44M |
| 160 | VTYX | Ventyx Biosciences, Inc. | 994.46M | - | 1,497,237 | - |
| 161 | RAPT | RAPT Therapeutics, Inc. | 980.13M | 9.88% | 301,883 | - |
| 162 | IOVA | Iovance Biotherapeutics, Inc. | 928.91M | 5.41% | 20,602,991 | 250.43M |
| 163 | BCAX | Bicara Therapeutics Inc. | 922.53M | 0.90% | 322,225 | - |
| 164 | XNCR | Xencor, Inc. | 918.34M | -2.65% | 403,190 | 150.13M |
| 165 | CTMX | CytomX Therapeutics, Inc. | 917.49M | 27.41% | 11,554,198 | 113.63M |
| 166 | ANNX | Annexon, Inc. | 912.22M | -0.65% | 930,642 | - |
| 167 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 908.67M | -1.22% | 141,672 | - |
| 168 | AVBP | ArriVent BioPharma, Inc. | 878.20M | -2.86% | 224,400 | - |
| 169 | DRUG | Bright Minds Biosciences Inc. | 876.65M | -3.34% | 70,714 | - |
| 170 | URGN | UroGen Pharma Ltd. | 876.50M | -4.17% | 397,197 | 96.52M |
| 171 | DBVT | DBV Technologies S.A. | 856.37M | 10.64% | 600,690 | 5.50M |
| 172 | VALN | Valneva SE | 855.98M | 0.53% | 2,431 | 211.09M |
| 173 | OMER | Omeros Corporation | 851.87M | -1.60% | 2,051,325 | - |
| 174 | VIR | Vir Biotechnology, Inc. | 843.10M | -2.26% | 1,045,990 | 16.86M |
| 175 | GERN | Geron Corporation | 839.31M | 1.14% | 12,070,670 | 183.40M |
| 176 | JANX | Janux Therapeutics, Inc. | 818.01M | -0.87% | 713,651 | 10.00M |
| 177 | MDXG | MiMedx Group, Inc. | 805.68M | -5.39% | 1,207,046 | 393.44M |
| 178 | YDES | YD Bio Limited | 796.72M | -0.79% | 24,959 | 510.36K |
| 179 | ARVN | Arvinas, Inc. | 785.78M | 0.87% | 405,567 | 312.30M |
| 180 | ABUS | Arbutus Biopharma Corporation | 778.91M | -13.83% | 7,985,652 | 14.61M |
| 181 | NKTR | Nektar Therapeutics | 762.00M | 5.94% | 531,908 | 62.60M |
| 182 | MPLT | MapLight Therapeutics, Inc. | 752.38M | -6.71% | 182,858 | - |
| 183 | KURA | Kura Oncology, Inc. | 741.82M | -4.32% | 1,760,334 | 104.03M |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 738.48M | -2.34% | 822,717 | 1.43M |
| 185 | ATXS | Astria Therapeutics, Inc. | 711.56M | -2.69% | 1,170,796 | 706.00K |
| 186 | PRME | Prime Medicine, Inc. | 709.92M | 0.50% | 3,024,702 | 5.98M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 697.13M | -0.39% | 19,765 | 107.27M |
| 188 | IVVD | Invivyd, Inc. | 695.10M | 1.02% | 1,232,702 | 50.04M |
| 189 | PROK | ProKidney Corp. | 691.92M | 5.50% | 1,270,646 | 744.00K |
| 190 | JBIO | Jade Biosciences, Inc. | 689.60M | 1.97% | 150,407 | - |
| 191 | RGNX | REGENXBIO Inc. | 688.98M | -1.09% | 456,137 | 161.32M |
| 192 | RIGL | Rigel Pharmaceuticals, Inc. | 682.49M | -0.48% | 205,269 | 282.08M |
| 193 | SLS | SELLAS Life Sciences Group, Inc. | 679.43M | 3.91% | 6,328,588 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 661.68M | -3.37% | 950,814 | 80.00M |
| 195 | TENX | Tenax Therapeutics, Inc. | 660.49M | 2.39% | 142,385 | - |
| 196 | ENGN | enGene Holdings Inc. | 634.68M | 2.77% | 169,095 | - |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 633.89M | 0.66% | 433,851 | - |
| 198 | VOR | Vor Biopharma Inc. | 609.07M | 11.88% | 846,722 | - |
| 199 | DRTS | Alpha Tau Medical Ltd. | 604.52M | -7.68% | 349,260 | - |
| 200 | FBRX | Forte Biosciences, Inc. | 597.71M | 2.54% | 81,764 | - |
| 201 | MGTX | MeiraGTx Holdings plc | 597.24M | -3.51% | 536,059 | 27.42M |
| 202 | CRVS | Corvus Pharmaceuticals, Inc. | 595.96M | 11.76% | 2,194,670 | - |
| 203 | GOSS | Gossamer Bio, Inc. | 584.43M | 3.06% | 3,265,659 | 44.05M |
| 204 | KROS | Keros Therapeutics, Inc. | 573.98M | -2.18% | 187,201 | 246.72M |
| 205 | LENZ | LENZ Therapeutics, Inc. | 566.97M | -0.11% | 531,444 | 17.50M |
| 206 | REPL | Replimune Group, Inc. | 553.81M | -3.29% | 1,956,809 | - |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 546.76M | 0.42% | 676,467 | 180.61M |
| 208 | ANRO | Alto Neuroscience, Inc. | 538.38M | 1.82% | 145,899 | - |
| 209 | LXEO | Lexeo Therapeutics, Inc. | 536.82M | -1.93% | 633,400 | - |
| 210 | CRMD | CorMedix Inc. | 534.98M | -3.14% | 2,209,190 | 214.30M |
| 211 | OCGN | Ocugen, Inc. | 532.51M | 5.25% | 7,458,861 | 5.37M |
| 212 | DSGN | Design Therapeutics, Inc. | 529.19M | -0.75% | 179,035 | - |
| 213 | EVMN | Evommune, Inc. | 527.40M | -14.64% | 167,654 | 13.00M |
| 214 | VSTM | Verastem, Inc. | 520.21M | 2.12% | 1,549,785 | 13.38M |
| 215 | LYEL | Lyell Immunopharma, Inc. | 506.67M | 4.01% | 134,255 | 41.00K |
| 216 | LXRX | Lexicon Pharmaceuticals, Inc. | 505.12M | 8.59% | 2,617,443 | 70.86M |
| 217 | PRTA | Prothena Corporation plc | 504.39M | 1.19% | 567,504 | 11.79M |
| 218 | LBRX | LB Pharmaceuticals Inc | 503.07M | -6.99% | 176,732 | - |
| 219 | ZVRA | Zevra Therapeutics, Inc. | 502.74M | -1.00% | 487,316 | 84.39M |
| 220 | NAGE | Niagen Bioscience, Inc. | 494.95M | -2.06% | 453,156 | 124.71M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 477.60M | -4.13% | 429,989 | - |
| 222 | MNPR | Monopar Therapeutics Inc. | 469.32M | 1.68% | 274,055 | - |
| 223 | ALT | Altimmune, Inc. | 465.55M | 0.59% | 2,026,212 | 20.00K |
| 224 | ASMB | Assembly Biosciences, Inc. | 462.18M | -2.31% | 102,592 | 37.19M |
| 225 | VTVT | vTv Therapeutics Inc. | 459.13M | -0.67% | 19,640 | 17.00K |
| 226 | ABSI | Absci Corporation | 458.63M | - | 2,026,752 | 2.82M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 452.03M | -0.23% | 78,446 | - |
| 228 | BCYC | Bicycle Therapeutics plc | 451.59M | 0.62% | 281,786 | 28.34M |
| 229 | AVXL | Anavex Life Sciences Corp. | 448.53M | 3.51% | 1,382,545 | - |
| 230 | PRTC | PureTech Health plc | 439.93M | -0.26% | 6,776 | 6.39M |
| 231 | ADCT | ADC Therapeutics SA | 439.76M | - | 589,299 | 75.21M |
| 232 | CTNM | Contineum Therapeutics, Inc. | 437.26M | 1.10% | 166,225 | - |
| 233 | VNDA | Vanda Pharmaceuticals Inc. | 436.72M | -0.81% | 659,747 | 212.07M |
| 234 | IMMP | Immutep Limited | 435.08M | -2.64% | 92,680 | 3.31M |
| 235 | NBP | NovaBridge Biosciences | 432.92M | 2.60% | 592,874 | - |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 430.80M | -0.92% | 579,496 | 120.00K |
| 237 | SLDB | Solid Biosciences Inc. | 430.45M | -2.39% | 590,859 | - |
| 238 | LCTX | Lineage Cell Therapeutics, Inc. | 410.75M | 2.73% | 1,213,887 | 10.82M |
| 239 | DMAC | DiaMedica Therapeutics Inc. | 406.12M | -11.24% | 553,488 | - |
| 240 | RCKT | Rocket Pharmaceuticals, Inc. | 398.80M | -0.67% | 2,445,724 | - |
| 241 | BNTC | Benitec Biopharma Inc. | 397.88M | 0.34% | 47,481 | - |
| 242 | TRDA | Entrada Therapeutics, Inc. | 397.42M | 2.42% | 226,145 | 61.52M |
| 243 | HELP | Cybin Inc. | 387.25M | -1.15% | 215,059 | - |
| 244 | GLSI | Greenwich LifeSciences, Inc. | 368.53M | -2.17% | 608,337 | - |
| 245 | AUTL | Autolus Therapeutics plc | 367.28M | -4.17% | 1,495,596 | 51.13M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 366.56M | -4.87% | 225,474 | 65.32M |
| 247 | ALLO | Allogene Therapeutics, Inc. | 365.19M | 0.93% | 4,273,888 | 22.00K |
| 248 | NMRA | Neumora Therapeutics, Inc. | 358.57M | -0.94% | 726,822 | - |
| 249 | PEPG | PepGen Inc. | 356.46M | 3.91% | 594,238 | - |
| 250 | CADL | Candel Therapeutics, Inc. | 355.19M | 8.92% | 1,004,489 | - |
| 251 | FHTX | Foghorn Therapeutics Inc. | 355.00M | -3.50% | 109,354 | 24.52M |
| 252 | TECX | Tectonic Therapeutic, Inc. | 353.92M | -3.08% | 252,271 | - |
| 253 | ACIU | AC Immune SA | 346.30M | -3.58% | 156,930 | 5.48M |
| 254 | AARD | Aardvark Therapeutics, Inc. | 333.35M | -0.26% | 108,683 | - |
| 255 | XOMA | XOMA Royalty Corporation | 327.29M | -8.20% | 1,154,648 | 47.11M |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 325.70M | 2.90% | 210,641 | 33.98M |
| 257 | PBYI | Puma Biotechnology, Inc. | 320.49M | -0.31% | 163,403 | 212.00M |
| 258 | AURA | Aura Biosciences, Inc. | 319.42M | -1.57% | 106,554 | - |
| 259 | ZURA | Zura Bio Limited | 317.96M | 4.26% | 1,584,079 | - |
| 260 | ACHV | Achieve Life Sciences, Inc. | 308.22M | 3.58% | 1,090,402 | - |
| 261 | IMRX | Immuneering Corporation | 299.60M | - | 1,268,583 | - |
| 262 | STTK | Shattuck Labs, Inc. | 293.30M | 3.69% | 331,578 | 1.00M |
| 263 | CLLS | Cellectis S.A. | 292.79M | 0.12% | 65,392 | 82.55M |
| 264 | CAMP | Camp4 Therapeutics Corporation | 288.98M | -3.63% | 77,702 | 3.80M |
| 265 | ACRS | Aclaris Therapeutics, Inc. | 284.95M | -1.50% | 604,117 | 15.74M |
| 266 | ABEO | Abeona Therapeutics Inc. | 284.23M | -3.76% | 1,946,415 | 400.00K |
| 267 | ALDX | Aldeyra Therapeutics, Inc. | 283.37M | 6.80% | 1,303,891 | - |
| 268 | RLMD | Relmada Therapeutics, Inc. | 277.20M | -0.53% | 386,211 | - |
| 269 | AVTX | Avalo Therapeutics, Inc. | 276.21M | -4.60% | 239,341 | 192.00K |
| 270 | NGNE | Neurogene Inc. | 275.10M | -1.66% | 67,711 | 925.00K |
| 271 | OABI | OmniAb, Inc. | 274.24M | -0.78% | 320,263 | 21.09M |
| 272 | HRTX | Heron Therapeutics, Inc. | 272.29M | -0.34% | 605,539 | 155.10M |
| 273 | TARA | Protara Therapeutics, Inc. | 269.01M | -0.40% | 1,037,519 | - |
| 274 | LRMR | Larimar Therapeutics, Inc. | 266.19M | -4.60% | 1,314,967 | - |
| 275 | GUTS | Fractyl Health, Inc. | 265.18M | -1.78% | 1,812,400 | 3.00K |
| 276 | AVIR | Atea Pharmaceuticals, Inc. | 264.46M | -1.60% | 244,801 | - |
| 277 | CBIO | Crescent Biopharma, Inc. | 261.18M | 6.88% | 141,887 | - |
| 278 | FENC | Fennec Pharmaceuticals Inc. | 259.57M | 1.88% | 70,368 | 38.79M |
| 279 | RZLT | Rezolute, Inc. | 257.78M | -1.07% | 3,249,874 | - |
| 280 | MENS | Jyong Biotech Ltd. | 254.54M | -4.34% | 380,427 | - |
| 281 | NAUT | Nautilus Biotechnology, Inc. | 253.87M | 9.84% | 428,746 | - |
| 282 | IMMX | Immix Biopharma, Inc. | 250.83M | 1.06% | 642,808 | - |
| 283 | PALI | Palisade Bio, Inc. | 249.58M | -4.29% | 8,932,827 | - |
| 284 | SLN | Silence Therapeutics plc | 239.48M | -8.81% | 272,268 | 25.83M |
| 285 | OBIO | Orchestra BioMed Holdings, Inc. | 237.15M | 0.72% | 101,048 | 2.82M |
| 286 | ARMP | Armata Pharmaceuticals, Inc. | 233.19M | 0.39% | 48,757 | 5.05M |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 229.11M | 1.52% | 271,360 | 1.00 |
| 288 | ENLV | Enlivex Therapeutics Ltd. | 222.85M | 0.54% | 342,034 | - |
| 289 | CGEN | Compugen Ltd. | 219.34M | 11.14% | 968,003 | 6.90M |
| 290 | NVCT | Nuvectis Pharma, Inc. | 217.85M | -0.29% | 42,747 | - |
| 291 | CCCC | C4 Therapeutics, Inc. | 217.09M | 0.90% | 1,046,117 | 30.11M |
| 292 | HUMA | Humacyte, Inc. | 215.19M | 1.36% | 3,199,517 | 1.57M |
| 293 | TNXP | Tonix Pharmaceuticals Holding Corp. | 212.76M | 7.99% | 429,790 | 10.30M |
| 294 | CABA | Cabaletta Bio, Inc. | 212.26M | 6.01% | 1,721,630 | - |
| 295 | MDWD | MediWound Ltd. | 209.50M | -5.93% | 166,972 | 20.93M |
| 296 | VYGR | Voyager Therapeutics, Inc. | 209.06M | -1.57% | 456,681 | 31.32M |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 207.99M | -3.81% | 293,216 | 97.60M |
| 298 | MIST | Milestone Pharmaceuticals Inc. | 207.74M | 0.74% | 2,267,113 | - |
| 299 | OVID | Ovid Therapeutics Inc. | 205.69M | -0.63% | 630,487 | 6.61M |
| 300 | ALEC | Alector, Inc. | 203.57M | 2.47% | 965,496 | 69.05M |
| 301 | TLSA | Tiziana Life Sciences Ltd | 203.19M | 17.93% | 1,389,579 | - |
| 302 | SGMT | Sagimet Biosciences Inc. | 200.66M | -1.44% | 357,018 | - |
| 303 | CLYM | Climb Bio, Inc. | 200.53M | 11.41% | 576,969 | - |
| 304 | EDIT | Editas Medicine, Inc. | 197.68M | -3.11% | 1,781,223 | 46.38M |
| 305 | QNCX | Quince Therapeutics, Inc. | 197.11M | 22.92% | 2,683,908 | - |
| 306 | GALT | Galectin Therapeutics Inc. | 196.64M | -3.17% | 431,786 | - |
| 307 | CHRS | Coherus Oncology, Inc. | 195.16M | -2.73% | 776,133 | 277.73M |
| 308 | CRDF | Cardiff Oncology, Inc. | 195.01M | 3.76% | 615,849 | 501.00K |
| 309 | NERV | Minerva Neurosciences, Inc. | 194.95M | 4.04% | 27,787 | - |
| 310 | RNAC | Cartesian Therapeutics, Inc. | 194.64M | 1.70% | 121,199 | 1.09M |
| 311 | ZNTL | Zentalis Pharmaceuticals, Inc. | 191.01M | -6.65% | 1,052,221 | 26.87M |
| 312 | SABS | SAB Biotherapeutics, Inc. | 189.00M | -0.75% | 624,578 | 114.70K |
| 313 | IPSC | Century Therapeutics, Inc. | 188.60M | -6.09% | 708,929 | 113.34M |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 188.04M | -1.19% | 8,601 | 18.97M |
| 315 | KLRS | Kalaris Therapeutics, Inc. | 184.22M | 11.17% | 89,973 | - |
| 316 | PRQR | ProQR Therapeutics N.V. | 174.87M | 5.06% | 538,009 | 18.86M |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 173.81M | 2.59% | 69,140 | 59.99K |
| 318 | VXRT | Vaxart, Inc. | 171.95M | 10.23% | 1,313,701 | 148.20M |
| 319 | SRZN | Surrozen, Inc. | 171.60M | 0.10% | 28,663 | 3.60M |
| 320 | RANI | Rani Therapeutics Holdings, Inc. | 169.52M | 0.36% | 935,237 | 1.20M |
| 321 | ELDN | Eledon Pharmaceuticals, Inc. | 168.23M | 2.42% | 856,492 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 164.86M | -0.49% | 301,862 | 61.84M |
| 323 | IPHA | Innate Pharma S.A. | 161.03M | 1.70% | 40,877 | 14.84M |
| 324 | TNYA | Tenaya Therapeutics, Inc. | 156.97M | -1.64% | 3,276,742 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 155.64M | 2.82% | 116,126 | - |
| 326 | CDXS | Codexis, Inc. | 151.29M | -5.90% | 271,935 | 52.93M |
| 327 | PRLD | Prelude Therapeutics Incorporated | 150.79M | -14.88% | 1,327,996 | 10.50M |
| 328 | MOLN | Molecular Partners AG | 148.66M | -1.87% | 1,293 | 856.30K |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 146.87M | - | 281,227 | 2.00M |
| 330 | IRD | Opus Genetics, Inc. | 146.20M | 1.92% | 171,489 | 14.63M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 145.57M | -4.31% | 1,102,901 | 70.00M |
| 332 | ELTX | Elicio Therapeutics, Inc. | 145.22M | 6.40% | 112,712 | - |
| 333 | NKTX | Nkarta, Inc. | 144.55M | 3.83% | 817,472 | - |
| 334 | MCRB | Seres Therapeutics, Inc. | 144.11M | 4.94% | 34,939 | 351.00K |
| 335 | WHWK | Whitehawk Therapeutics, Inc. | 139.03M | 5.73% | 125,186 | 14.38M |
| 336 | SGMO | Sangamo Therapeutics, Inc. | 137.96M | -4.65% | 6,234,455 | 32.88M |
| 337 | CRBU | Caribou Biosciences, Inc. | 137.87M | -5.45% | 2,376,371 | 9.30M |
| 338 | FATE | Fate Therapeutics, Inc. | 136.69M | 12.86% | 4,326,421 | 7.14M |
| 339 | TTRX | Turn Therapeutics Inc. | 135.74M | -4.36% | 24,240 | - |
| 340 | SPRO | Spero Therapeutics, Inc. | 135.21M | - | 218,079 | 40.55M |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 133.25M | -1.12% | 493,879 | - |
| 342 | CNTX | Context Therapeutics Inc. | 132.77M | -4.93% | 874,983 | - |
| 343 | ACTU | Actuate Therapeutics, Inc. | 130.51M | 5.55% | 32,268 | - |
| 344 | CGTX | Cognition Therapeutics, Inc. | 129.32M | 6.16% | 1,135,348 | - |
| 345 | ACOG | Alpha Cognition Inc. | 123.50M | -2.41% | 79,115 | 7.43M |
| 346 | GNLX | Genelux Corporation | 121.34M | 7.03% | 306,013 | 8.00K |
| 347 | CNTB | Connect Biopharma Holdings Limited | 121.31M | -2.25% | 114,245 | 762.00K |
| 348 | STRO | Sutro Biopharma, Inc. | 119.27M | 7.12% | 81,578 | 105.65M |
| 349 | FBIO | Fortress Biotech, Inc. | 116.39M | 7.76% | 764,751 | 62.30M |
| 350 | VRCA | Verrica Pharmaceuticals Inc. | 115.93M | -4.73% | 361,955 | 30.83M |
| 351 | KPTI | Karyopharm Therapeutics Inc. | 115.90M | -4.95% | 346,748 | 142.53M |
| 352 | ABOS | Acumen Pharmaceuticals, Inc. | 115.13M | 2.18% | 294,636 | - |
| 353 | AGEN | Agenus Inc. | 112.74M | -9.92% | 1,528,297 | 106.83M |
| 354 | ONCY | Oncolytics Biotech Inc. | 111.91M | 6.89% | 1,757,616 | - |
| 355 | PYXS | Pyxis Oncology, Inc. | 110.83M | -3.26% | 1,855,348 | 2.82M |
| 356 | RPTX | Repare Therapeutics Inc. | 110.57M | -0.19% | 327,444 | 11.87M |
| 357 | THAR | Tharimmune, Inc. | 110.29M | -0.34% | 270,936 | - |
| 358 | MGNX | MacroGenics, Inc. | 107.54M | - | 1,178,568 | 127.63M |
| 359 | ARTV | Artiva Biotherapeutics, Inc. | 106.77M | -2.47% | 136,400 | 251.00K |
| 360 | SEER | Seer, Inc. | 106.32M | -1.05% | 114,670 | 16.38M |
| 361 | ETHZ | ETHZilla Corporation | 106.28M | 3.14% | 441,031 | 4.11M |
| 362 | ANIX | Anixa Biosciences, Inc. | 106.09M | -1.28% | 178,886 | - |
| 363 | INO | Inovio Pharmaceuticals, Inc. | 105.12M | -3.16% | 1,198,776 | 182.34K |
| 364 | CBUS | Cibus, Inc. | 102.48M | 1.61% | 245,753 | 3.79M |
| 365 | MREO | Mereo BioPharma Group plc | 101.94M | -4.46% | 13,461,266 | 500.00K |
| 366 | CSBR | Champions Oncology, Inc. | 100.40M | 0.80% | 2,499 | 58.42M |
| 367 | BMEA | Biomea Fusion, Inc. | 99.69M | 1.08% | 1,456,650 | - |
| 368 | DTIL | Precision BioSciences, Inc. | 98.21M | 4.62% | 168,341 | 698.00K |
| 369 | SAVA | Cassava Sciences, Inc. | 97.82M | -4.93% | 1,013,701 | - |
| 370 | HYFT | MindWalk Holdings Corp. | 97.12M | 4.00% | 570,380 | 19.02M |
| 371 | VANI | Vivani Medical, Inc. | 92.65M | 0.79% | 65,547 | - |
| 372 | ADAG | Adagene Inc. | 92.38M | 2.08% | 41,633 | 103.20K |
| 373 | EXOZ | eXoZymes, Inc. | 92.34M | 2.23% | 9,520 | -700.00 |
| 374 | COYA | Coya Therapeutics, Inc. | 88.93M | 5.46% | 356,118 | 3.99M |
| 375 | DWTX | Dogwood Therapeutics, Inc. | 87.59M | -2.50% | 19,749 | - |
| 376 | ACET | Adicet Bio, Inc. | 83.28M | 3.78% | 105,098 | - |
| 377 | OKYO | OKYO Pharma Limited | 83.12M | -7.53% | 172,018 | - |
| 378 | KRRO | Korro Bio, Inc. | 82.68M | -0.23% | 78,056 | 7.37M |
| 379 | ATOS | Atossa Therapeutics, Inc. | 80.33M | 7.20% | 1,643,952 | - |
| 380 | PLRX | Pliant Therapeutics, Inc. | 79.27M | 0.78% | 473,583 | - |
| 381 | SPRB | Spruce Biosciences, Inc. | 79.21M | -1.19% | 17,031 | 697.00K |
| 382 | MNOV | MediciNova, Inc. | 79.13M | 1.90% | 60,958 | 257.92K |
| 383 | XBIT | XBiotech Inc. | 78.20M | 1.38% | 5,649 | - |
| 384 | KZIA | Kazia Therapeutics Limited | 77.96M | 2.07% | 163,891 | 1.20M |
| 385 | ANVS | Annovis Bio, Inc. | 76.73M | -9.53% | 724,402 | - |
| 386 | CALC | CalciMedica, Inc. | 75.94M | -0.19% | 19,495 | - |
| 387 | IMUX | Immunic, Inc. | 75.53M | -1.72% | 1,194,205 | - |
| 388 | ENTX | Entera Bio Ltd. | 74.75M | 3.16% | 95,749 | 124.00K |
| 389 | PTHS | Pelthos Therapeutics Inc. | 74.39M | -7.09% | 13,010 | 7.41M |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 73.98M | -4.58% | 59,267 | 501.00K |
| 391 | PYPD | PolyPid Ltd. | 72.86M | -0.23% | 52,084 | - |
| 392 | IMA | ImageneBio, Inc. | 70.53M | 0.64% | 5,831 | 800.00K |
| 393 | EQ | Equillium, Inc. | 70.33M | 8.96% | 501,021 | 4.39M |
| 394 | ATYR | aTyr Pharma, Inc. | 69.84M | 0.88% | 1,065,432 | 190.00K |
| 395 | IFRX | InflaRx N.V. | 69.10M | 2.00% | 430,184 | 73.73K |
| 396 | GANX | Gain Therapeutics, Inc. | 68.27M | -5.59% | 1,510,358 | - |
| 397 | ANL | Adlai Nortye Ltd. | 68.27M | 10.12% | 107,556 | -1.35M |
| 398 | BYSI | BeyondSpring Inc. | 68.26M | -6.21% | 9,894 | 1.88M |
| 399 | NRXP | NRx Pharmaceuticals, Inc. | 67.35M | 5.81% | 1,418,305 | 242.00K |
| 400 | TVGN | Tevogen Bio Holdings Inc. | 67.02M | 3.34% | 185,043 | - |
| 401 | MAIA | MAIA Biotechnology, Inc. | 66.97M | 10.06% | 2,359,814 | - |
| 402 | TCRX | TScan Therapeutics, Inc. | 66.11M | 2.19% | 574,051 | 8.42M |
| 403 | CRVO | CervoMed Inc. | 65.79M | 0.42% | 51,528 | 6.16M |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 63.58M | 7.75% | 1,506,047 | - |
| 405 | MGX | Metagenomi Therapeutics, Inc. | 63.38M | -0.11% | 157,691 | 30.91M |
| 406 | ALXO | ALX Oncology Holdings Inc. | 63.16M | -3.72% | 172,108 | - |
| 407 | LPCN | Lipocine Inc. | 63.01M | 0.80% | 151,762 | 4.32M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 60.13M | -0.88% | 206,222 | - |
| 409 | RADX | Radiopharm Theranostics Limited | 59.45M | 0.97% | 20,246 | 8.20M |
| 410 | ATHE | Alterity Therapeutics Limited | 58.38M | -0.30% | 12,767 | 3.57M |
| 411 | ICCC | ImmuCell Corporation | 57.98M | -3.46% | 30,148 | 27.77M |
| 412 | INKT | MiNK Therapeutics, Inc. | 56.61M | 1.94% | 3,526 | - |
| 413 | GRCE | Grace Therapeutics, Inc. | 56.17M | -0.27% | 34,283 | - |
| 414 | NTRB | Nutriband Inc. | 54.46M | 2.51% | 9,397 | 2.28M |
| 415 | PDSB | PDS Biotechnology Corporation | 53.09M | 2.70% | 487,192 | - |
| 416 | LITS | Lite Strategy, Inc. | 51.85M | 0.71% | 437,183 | - |
| 417 | PSTV | Plus Therapeutics, Inc. | 51.32M | 3.94% | 19,780,687 | 5.26M |
| 418 | OSTX | OS Therapies Incorporated | 51.06M | -0.68% | 382,961 | - |
| 419 | IBIO | iBio, Inc. | 50.93M | 2.49% | 774,500 | 500.00K |
| 420 | ALGS | Aligos Therapeutics, Inc. | 49.72M | -2.18% | 55,783 | 2.65M |
| 421 | NRXS | NeurAxis, Inc. | 49.11M | 0.22% | 41,317 | 3.36M |
| 422 | TIL | Instil Bio, Inc. | 48.63M | 0.84% | 47,859 | - |
| 423 | ABVC | ABVC BioPharma, Inc. | 48.32M | - | 39,158 | 797.92K |
| 424 | TELO | Telomir Pharmaceuticals, Inc. | 47.96M | 1.82% | 140,708 | - |
| 425 | IBO | Impact BioMedical Inc. | 47.35M | -4.70% | 34,713 | 25.00K |
| 426 | HURA | TuHURA Biosciences, Inc. | 46.83M | 1.42% | 224,712 | - |
| 427 | NXTC | NextCure, Inc. | 46.49M | 3.04% | 28,995 | - |
| 428 | INMB | INmune Bio, Inc. | 45.99M | 6.13% | 300,641 | 50.00K |
| 429 | APLM | Apollomics, Inc. | 45.65M | 5.61% | 3,374 | 6.93M |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.11M | -0.65% | 9,160 | - |
| 431 | CVM | CEL-SCI Corporation | 44.57M | 6.21% | 64,722 | - |
| 432 | QTTB | Q32 Bio Inc. | 44.42M | 0.28% | 73,778 | - |
| 433 | ANEB | Anebulo Pharmaceuticals, Inc. | 43.55M | 1.91% | 100,432 | - |
| 434 | JSPR | Jasper Therapeutics, Inc. | 43.24M | 1.64% | 245,829 | - |
| 435 | XLO | Xilio Therapeutics, Inc. | 43.16M | -0.17% | 95,737 | 31.80M |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 42.69M | 0.89% | 13,608 | - |
| 437 | VERU | Veru Inc. | 42.45M | 9.30% | 221,228 | 16.89M |
| 438 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 41.74M | 1.94% | 4,600,519 | - |
| 439 | ESLA | Estrella Immunopharma, Inc. | 41.70M | 2.27% | 87,117 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 41.49M | 1.53% | 59,807 | 90.00K |
| 441 | OKUR | OnKure Therapeutics, Inc. | 40.85M | 0.17% | 21,261 | - |
| 442 | CING | Cingulate Inc. | 40.66M | 4.04% | 187,688 | - |
| 443 | PASG | Passage Bio, Inc. | 40.40M | -10.99% | 32,197 | - |
| 444 | GLTO | Galecto, Inc. | 39.56M | 3.55% | 28,325 | - |
| 445 | XCUR | Exicure, Inc. | 39.07M | -1.92% | 36,854 | 500.00K |
| 446 | LTRN | Lantern Pharma Inc. | 38.25M | -2.56% | 39,045 | - |
| 447 | CELU | Celularity Inc. | 38.21M | 2.71% | 25,471 | 40.58M |
| 448 | EVAX | Evaxion A/S | 38.11M | -4.59% | 90,989 | 7.65M |
| 449 | GBIO | Generation Bio Co. | 37.93M | -0.35% | 90,579 | 15.27M |
| 450 | RNXT | RenovoRx, Inc. | 37.75M | - | 146,686 | 928.00K |
| 451 | KYNB | Kyntra Bio, Inc. | 36.93M | 0.66% | 8,839 | 8.30M |
| 452 | IOBT | IO Biotech, Inc. | 36.49M | -1.71% | 363,015 | - |
| 453 | OTLK | Outlook Therapeutics, Inc. | 34.70M | 3.64% | 1,693,478 | 1.41M |
| 454 | ANTX | AN2 Therapeutics, Inc. | 34.53M | 0.80% | 10,725 | - |
| 455 | SKYE | Skye Bioscience, Inc. | 33.31M | 7.94% | 207,641 | - |
| 456 | ATRA | Atara Biotherapeutics, Inc. | 32.88M | -1.30% | 462,183 | 151.93M |
| 457 | BCTX | BriaCell Therapeutics Corp. | 32.62M | -4.90% | 704,233 | - |
| 458 | SER | Serina Therapeutics, Inc. | 32.31M | 12.64% | 140,433 | 116.00K |
| 459 | RNTX | Rein Therapeutics Inc. | 32.07M | 5.17% | 66,473 | - |
| 460 | DYAI | Dyadic International, Inc. | 31.88M | -1.01% | 11,790 | 3.34M |
| 461 | GNTA | Genenta Science S.p.A. | 30.70M | -5.07% | 73,908 | - |
| 462 | MRKR | Marker Therapeutics, Inc. | 30.43M | 3.69% | 214,358 | 4.69M |
| 463 | BRNS | Barinthus Biotherapeutics plc | 29.99M | 0.62% | 17,836 | 14.97M |
| 464 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.36M | -1.17% | 130,791 | - |
| 465 | JUNS | Jupiter Neurosciences, Inc. | 29.18M | -1.69% | 51,793 | - |
| 466 | PLUR | Pluri Inc. | 29.15M | 3.61% | 12,466 | 1.33M |
| 467 | PTN | Palatin Technologies, Inc. | 28.83M | 6.94% | 34,190 | 8.85M |
| 468 | RLYB | Rallybio Corporation | 28.13M | -1.48% | 180,242 | 674.00K |
| 469 | IGC | IGC Pharma, Inc. | 28.04M | 0.79% | 407,423 | 1.11M |
| 470 | BOLD | Boundless Bio, Inc. | 27.98M | - | 29,084 | - |
| 471 | NRSN | NeuroSense Therapeutics Ltd. | 27.62M | -6.10% | 89,091 | - |
| 472 | DARE | Daré Bioscience, Inc. | 27.58M | -1.03% | 42,393 | -57.13K |
| 473 | CUE | Cue Biopharma, Inc. | 27.52M | 8.88% | 1,216,711 | 7.10M |
| 474 | SNTI | Senti Biosciences, Inc. | 27.47M | -1.42% | 137,413 | - |
| 475 | QNTM | Quantum BioPharma Ltd. | 27.43M | 1.29% | 22,843 | - |
| 476 | HYPD | Hyperion DeFi, Inc. | 26.87M | -4.48% | 179,153 | 345.32K |
| 477 | HOWL | Werewolf Therapeutics, Inc. | 26.79M | 0.18% | 530,014 | 1.14M |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 26.51M | 0.03% | 1,021,479 | 721.00K |
| 479 | NNVC | NanoViricides, Inc. | 25.45M | 4.42% | 202,439 | - |
| 480 | PLRZ | Polyrizon Ltd. | 24.82M | 0.19% | 46,352 | - |
| 481 | INTS | Intensity Therapeutics, Inc. | 24.69M | -1.67% | 668,315 | - |
| 482 | LONA | LeonaBio, Inc. | 23.98M | -4.03% | 73,096 | - |
| 483 | KLTO | Klotho Neurosciences, Inc. | 23.86M | 3.61% | 337,334 | - |
| 484 | FBLG | FibroBiologics, Inc. | 22.65M | 0.90% | 480,831 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 22.34M | 1.34% | 52,845 | 15.65M |
| 486 | LNAI | Lunai Bioworks Inc. | 21.56M | 0.10% | 69,106 | - |
| 487 | LIMN | Liminatus Pharma, Inc. | 20.71M | -1.77% | 60,039 | - |
| 488 | ALLR | Allarity Therapeutics, Inc. | 20.66M | 0.85% | 45,439 | - |
| 489 | KTTA | Pasithea Therapeutics Corp. | 20.55M | 0.07% | 70,614 | - |
| 490 | LSTA | Lisata Therapeutics, Inc. | 19.76M | 2.75% | 24,589 | 1.07M |
| 491 | CASI | CASI Pharmaceuticals, Inc. | 19.52M | -8.64% | 21,995 | 26.85M |
| 492 | BCAB | BioAtla, Inc. | 19.38M | 2.69% | 1,653,771 | 11.00M |
| 493 | CLGN | CollPlant Biotechnologies Ltd. | 19.16M | -4.46% | 7,240 | 2.48M |
| 494 | KALA | KALA BIO, Inc. | 19.07M | 12.37% | 4,240,385 | - |
| 495 | OSRH | OSR Holdings, Inc. | 18.89M | -5.88% | 1,037,014 | -90.52K |
| 496 | VYNE | VYNE Therapeutics Inc. | 18.86M | -0.07% | 203,378 | 524.00K |
| 497 | CVKD | Cadrenal Therapeutics, Inc. | 18.65M | -2.73% | 40,706 | - |
| 498 | LEXX | Lexaria Bioscience Corp. | 18.19M | - | 62,664 | 522.00K |
| 499 | KAPA | Kairos Pharma, Ltd. | 18.02M | -2.76% | 44,567 | - |
| 500 | ITRM | Iterum Therapeutics plc | 17.97M | 5.65% | 275,314 | 390.00K |
| 501 | PMN | ProMIS Neurosciences, Inc. | 17.70M | 0.87% | 8,831 | - |
| 502 | CTXR | Citius Pharmaceuticals, Inc. | 17.44M | -1.91% | 253,013 | - |
| 503 | TRAW | Traws Pharma, Inc. | 16.46M | 19.77% | 969,139 | 2.85M |
| 504 | HOTH | Hoth Therapeutics, Inc. | 16.29M | -2.78% | 261,940 | - |
| 505 | COCP | Cocrystal Pharma, Inc. | 15.37M | 0.45% | 46,098 | - |
| 506 | CLRB | Cellectar Biosciences, Inc. | 15.31M | -1.10% | 32,157 | - |
| 507 | APLT | Applied Therapeutics, Inc. | 15.29M | -1.57% | 8,500,806 | 1.00M |
| 508 | BCDA | BioCardia, Inc. | 14.86M | - | 34,141 | 3.00K |
| 509 | SNGX | Soligenix, Inc. | 14.02M | 3.73% | 121,082 | 2.34K |
| 510 | NCNA | NuCana plc | 13.90M | - | 142,003 | - |
| 511 | TPST | Tempest Therapeutics, Inc. | 13.40M | 2.64% | 72,944 | - |
| 512 | AEON | AEON Biopharma, Inc. | 13.38M | -1.72% | 62,380 | - |
| 513 | SNSE | Sensei Biotherapeutics, Inc. | 13.32M | -9.04% | 66,830 | - |
| 514 | SYBX | Synlogic, Inc. | 13.22M | -0.88% | 4,842 | 8.00K |
| 515 | GRDX | GridAI Technologies Corp. | 12.94M | -2.78% | 106,102 | - |
| 516 | CRIS | Curis, Inc. | 12.86M | 4.75% | 552,760 | 11.65M |
| 517 | MBRX | Moleculin Biotech, Inc. | 12.84M | -2.34% | 117,897 | - |
| 518 | AKTX | Akari Therapeutics, Plc | 12.73M | 4.00% | 298,224 | - |
| 519 | BLRX | BioLineRx Ltd. | 12.46M | 0.23% | 46,769 | 12.74M |
| 520 | PHIO | Phio Pharmaceuticals Corp. | 12.23M | 0.58% | 116,182 | - |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 12.21M | -8.88% | 29,477 | 5.20M |
| 522 | EDSA | Edesa Biotech, Inc. | 12.19M | 2.98% | 10,273 | - |
| 523 | INAB | IN8bio, Inc. | 12.10M | 12.50% | 225,426 | - |
| 524 | LGVN | Longeveron Inc. | 11.84M | -1.61% | 65,838 | 1.44M |
| 525 | IMNN | Imunon, Inc. | 11.73M | -0.58% | 36,739 | - |
| 526 | GDTC | CytoMed Therapeutics Limited | 10.85M | 1.08% | 47,585 | 573.19K |
| 527 | NCEL | NewcelX Ltd. | 10.82M | -2.76% | 69,752 | - |
| 528 | CMMB | Chemomab Therapeutics Ltd. | 10.30M | -1.59% | 49,663 | - |
| 529 | BRTX | BioRestorative Therapies, Inc. | 10.21M | 3.59% | 14,400 | 383.40K |
| 530 | ABP | Abpro Holdings, Inc. | 9.51M | -1.69% | 6,503 | 183.00K |
| 531 | ERNA | Ernexa Therapeutics Inc. | 9.50M | 2.54% | 26,636 | 1,000.00 |
| 532 | PULM | Pulmatrix, Inc. | 9.48M | 2.57% | 14,666 | 3.00K |
| 533 | APVO | Aptevo Therapeutics Inc. | 9.37M | 3.99% | 64,682 | - |
| 534 | EVGN | Evogene Ltd. | 9.29M | -0.95% | 16,946 | 8.02M |
| 535 | PMCB | PharmaCyte Biotech, Inc. | 9.11M | -4.01% | 158,207 | - |
| 536 | ICU | SeaStar Medical Holding Corporation | 9.08M | -1.95% | 57,231 | 881.00K |
| 537 | XTLB | XTL Biopharmaceuticals Ltd. | 9.03M | 2.57% | 322,175 | 968.00K |
| 538 | IMRN | Immuron Limited | 8.95M | -1.38% | 52,743 | 4.78M |
| 539 | BIVI | BioVie Inc. | 8.93M | 0.42% | 91,640 | - |
| 540 | ALZN | Alzamend Neuro, Inc. | 8.85M | 3.45% | 76,605 | - |
| 541 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.60M | -3.85% | 43,396 | - |
| 542 | APM | Aptorum Group Limited | 8.47M | -0.95% | 13,885 | - |
| 543 | PCSA | Processa Pharmaceuticals, Inc. | 8.07M | -4.04% | 80,266 | - |
| 544 | KPRX | Kiora Pharmaceuticals, Inc. | 8.01M | -0.23% | 1,447 | 20.00K |
| 545 | ADXN | Addex Therapeutics Ltd | 7.99M | -1.23% | 4,393 | 198.82K |
| 546 | BGMS | Bio Green Med Solution, Inc. | 7.99M | 13.99% | 67,487 | 81.00K |
| 547 | GTBP | GT Biopharma, Inc. | 7.93M | 2.08% | 1,948,910 | - |
| 548 | RNAZ | TransCode Therapeutics, Inc. | 7.79M | -3.74% | 4,720 | - |
| 549 | MBIO | Mustang Bio, Inc. | 7.74M | 0.95% | 13,187 | - |
| 550 | CLDI | Calidi Biotherapeutics, Inc. | 7.61M | - | 91,295 | - |
| 551 | SLXN | Silexion Therapeutics Corp | 7.16M | -6.15% | 34,076 | - |
| 552 | TOVX | Theriva Biologics, Inc. | 7.05M | -4.58% | 3,878,370 | - |
| 553 | CELZ | Creative Medical Technology Holdings, Inc. | 7.02M | 5.79% | 77,785 | 6.00K |
| 554 | GNPX | Genprex, Inc. | 6.93M | -9.39% | 1,626,015 | - |
| 555 | MTVA | MetaVia Inc. | 6.71M | -7.58% | 512,167 | - |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 6.70M | 6.76% | 8,357 | 6.00K |
| 557 | JAGX | Jaguar Health, Inc. | 6.67M | 92.28% | 148,699,126 | 11.79M |
| 558 | PPBT | Purple Biotech Ltd | 6.50M | -2.80% | 50,750 | - |
| 559 | ADIL | Adial Pharmaceuticals, Inc. | 6.38M | 1.23% | 240,569 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 6.29M | 0.67% | 44,532 | 488.24K |
| 561 | ACXP | Acurx Pharmaceuticals, Inc. | 6.27M | -0.74% | 14,920 | - |
| 562 | INDP | Indaptus Therapeutics, Inc. | 5.94M | 12.25% | 226,352 | - |
| 563 | ASBP | Aspire Biopharma Holdings, Inc. | 5.78M | - | 1,131,206 | 1.94K |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.69M | -7.47% | 61,921 | 560.00K |
| 565 | DCOY | Decoy Therapeutics Inc. | 5.68M | -7.49% | 417,491 | - |
| 566 | REVB | Revelation Biosciences, Inc. | 5.66M | 6.12% | 46,687 | - |
| 567 | VIVS | VivoSim Labs, Inc. | 5.63M | 7.46% | 70,193 | 140.00K |
| 568 | XBIO | Xenetic Biosciences, Inc. | 5.59M | 7.04% | 76,051 | 2.86M |
| 569 | CYCN | Cyclerion Therapeutics, Inc. | 5.24M | 1.32% | 76,440 | 2.86M |
| 570 | GOVX | GeoVax Labs, Inc. | 5.18M | 5.79% | 218,061 | 3.35M |
| 571 | SILO | Silo Pharma, Inc. | 5.00M | -1.49% | 112,961 | 72.10K |
| 572 | CNSP | CNS Pharmaceuticals, Inc. | 4.53M | -0.81% | 46,226 | - |
| 573 | MTNB | Matinas BioPharma Holdings, Inc. | 4.42M | -1.43% | 33,749 | - |
| 574 | PPCB | Propanc Biopharma, Inc. | 4.30M | -8.45% | 248,191 | - |
| 575 | GLMD | Galmed Pharmaceuticals Ltd. | 4.22M | -1.66% | 69,809 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 4.07M | -2.60% | 23,398 | - |
| 577 | PHGE | BiomX Inc. | 4.03M | 1.16% | 17,283 | - |
| 578 | OGEN | Oragenics, Inc. | 3.96M | 1.36% | 26,794 | - |
| 579 | XRTX | XORTX Therapeutics Inc. | 3.91M | 0.01% | 15,592 | - |
| 580 | HCWB | HCW Biologics Inc. | 3.71M | 20.61% | 210,781 | 422.03K |
| 581 | CMND | Clearmind Medicine Inc. | 3.69M | -6.46% | 44,708 | - |
| 582 | SPRC | SciSparc Ltd. | 3.57M | 3.81% | 334,270 | 1.31M |
| 583 | LYRA | Lyra Therapeutics, Inc. | 3.52M | 2.06% | 39,695 | 600.00K |
| 584 | ARTL | Artelo Biosciences, Inc. | 3.45M | 3.01% | 88,492 | - |
| 585 | AZTR | Azitra, Inc. | 3.41M | -7.89% | 4,137,328 | 7.50K |
| 586 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.27M | 1.70% | 72,778 | 15.78K |
| 587 | BBLG | Bone Biologics Corporation | 3.20M | 6.59% | 131,987 | - |
| 588 | GRI | GRI Bio, Inc. | 3.18M | -5.32% | 895,314 | - |
| 589 | ENSC | Ensysce Biosciences, Inc. | 3.12M | -4.44% | 74,813 | 4.49M |
| 590 | SCNI | Scinai Immunotherapeutics Ltd. | 3.00M | -4.86% | 20,934 | 1.15M |
| 591 | DRMA | Dermata Therapeutics, Inc. | 2.68M | 1.33% | 449,662 | - |
| 592 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.61M | 32.30% | 3,008,845 | 1.36M |
| 593 | ONCO | Onconetix, Inc. | 2.52M | 0.62% | 12,417 | 1.22M |
| 594 | CDT | CDT Equity Inc. | 2.45M | 4.44% | 31,405 | - |
| 595 | VRAX | Virax Biolabs Group Limited | 2.30M | -1.21% | 215,781 | 2.99K |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.86M | 2.07% | 1,173,504 | 104.90K |
| 597 | ADTX | Aditxt, Inc. | 1.55M | 17.53% | 3,918,410 | 5.95K |
| 598 | MLEC | Moolec Science SA | 1.33M | -35.32% | 556,773 | 7.83M |
| 599 | PBM | Psyence Biomedical Ltd. | 1.27M | 1.06% | 429,238 | - |
| 600 | ELAB | PMGC Holdings Inc. | 600.88K | -12.94% | 353,051 | 285.95K |